Pursuant to Sections 70-72 of the Danish Companies Act, Asahi Kasei Pharma Denmark A/S today announces its notice on compulsory acquisition to the shareholders of
Reference is made to Asahi Kasei Pharma Denmark A/S' announcement attached to this company release.
Contact:
Tel: +1 919-591-3090
Email: IR@Veloxis.com
This announcement has been prepared both in English and Danish. In the event of any discrepancies between the English and Danish version, the English version shall prevail.
Attachments: Announcement from Asahi Kasei Pharma Denmark A/S.
About Veloxis
Veloxis is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients. A Danish company, Veloxis operates in the
(C) 2020 Electronic News Publishing, source